Clinicopathologic Features of BRAF V600E-Mutant Anaplastic Thyroid Carcinoma

被引：0
|
作者：
Chen, Tiffany
Wong, Kristine [1 ]
Barletta, Justine [2 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
574
引用
收藏
页码：571 / 572
页数：2
相关论文
共 50 条
  • [41] BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series
    Butt, Sabeeh-ur-Rehman
    Mejias, Alberto
    Morelli, Cristina
    Torga, Gonzalo
    Happe, Marlene
    Patrikidou, Anna
    Arkenau, Hendrik-Tobias
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (03) : 437 - 441
  • [42] Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
    Giles W Robinson
    Brent A Orr
    Amar Gajjar
    BMC Cancer, 14
  • [43] Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer
    Hamidi, Sarah
    Dadu, Ramona
    Zafereo, Mark E.
    Ferrarotto, Renata
    Wang, Jennifer R.
    Maniakas, Anastasios
    Gunn, G. Brandon
    Lee, Anna
    Spiotto, Michael T.
    Iyer, Priyanka C.
    Sousa, Luana G.
    Akhave, Neal S.
    Ahmed, Salmaan
    Learned, Kim O.
    Lu, Charles
    Lai, Stephen Y.
    Williams, Michelle
    Hosseini, S. Mohsen
    Busaidy, Naifa L.
    Cabanillas, Maria E.
    JAMA ONCOLOGY, 2024, 10 (09) : 1264 - 1271
  • [44] Effective treatment of a BRAF V600E-mutant epithelioid glioblastoma patient by vemurafenib: a case report
    Lin, Zhiying
    Xu, Haiyan
    Yang, Runwei
    Li, Zhiyong
    Zheng, Haojie
    Zhang, Zhu
    Peng, Junxiang
    Zhang, Xian
    Qi, Songtao
    Liu, Yawei
    Huang, Guanglong
    ANTI-CANCER DRUGS, 2022, 33 (01) : 100 - 104
  • [45] Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature
    Branco, Benoit
    Comont, Thibault
    Ysebaert, Loic
    Picard, Muriel
    Laurent, Camille
    Oberic, Lucie
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 444 - 448
  • [46] Effect of cyasterone on intestinal flora in a BRAF V600E-mutant mouse model of colorectal cancer
    Xiong, Ying
    Zheng, Xinyue
    Xie, Yongmei
    Gong, Youling
    Luo, Yi
    PHARMAZIE, 2022, 77 (10): : 291 - 294
  • [47] Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas
    Wang, Hechuan
    Long-Boyle, Janel
    Winger, Beth Apsel
    Nicolaides, Theodore
    Mueller, Sabine
    Prados, Michael
    Ivaturi, Vijay
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (09): : 1209 - 1219
  • [48] Concurrent involvement of the bone marrow by BRAF V600E-mutant melanoma and hairy cell leukemia
    Moore, Margaret
    Patel, Pranav
    Tao, Jianguo
    JOURNAL OF HEMATOPATHOLOGY, 2024, 17 (04) : 223 - 225
  • [49] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    LABORATORY INVESTIGATION, 2017, 97 : 327A - 327A
  • [50] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    MODERN PATHOLOGY, 2017, 30 : 327A - 327A
12345